cromakalim has been researched along with Migraine Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 8 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aziz, Q; Christensen, SL; Christensen, ST; Cour, S; Ernstsen, C; Guzaite, G; Hansen, TF; Janfelt, C; Jansen-Olesen, I; Kogelman, LJ; Kristensen, DM; Lauritzen, SP; Olesen, J; Rasmussen, RH; Styrishave, B; Tinker, A | 1 |
| Christensen, SL; Clement, A; Guo, S; Jansen-Olesen, I | 1 |
| Li, Z; Liu, X; Ren, X; Wang, W; Wang, Y; Wu, S; Zhang, K; Zhu, C | 1 |
| Ashina, M; Christensen, SL; Ernstsen, C; Guo, S; Hay-Schmidt, A; Kristensen, DM; Olesen, J | 1 |
| Akaydin, E; Alpay, B; Bolay, H; Cimen, B; Sara, Y | 1 |
| Al-Khazali, HM; Ashina, H; Burstein, R; Chaudhry, BA; Christensen, RH; Dodick, DW | 1 |
| Al-Karagholi, MA; Ashina, M; Kokoti, L | 1 |
| Chaker, J; Christensen, SL; Christensen, ST; David, A; Ernstsen, C; Haanes, KA; Kristensen, DM; La Cour, S; Olesen, J; Rasmussen, RH | 1 |
| Al-Karagholi, MA; Ashina, M; Hansen, JM; Jansen-Olesen, I; Severinsen, J | 1 |
| Levy, D; Zhao, J | 1 |
| Al-Karagholi, MA; Ashina, M; Guo, S; Hansen, JM; Olesen, J | 1 |
| Amrutkar, DV; Baun, M; Gupta, S; Hay-Schmidt, A; Iversen, A; Jansen-Olesen, I; Lund, TM; Olesen, J; Ploug, KB; Ramachandran, R | 1 |
2 review(s) available for cromakalim and Migraine Disorders
| Article | Year |
|---|---|
ATP-Sensitive Potassium Channels in Migraine: Translational Findings and Therapeutic Potential.
Topics: Adenosine Triphosphate; Cromakalim; Headache; Humans; KATP Channels; Migraine Disorders; Vasodilator Agents | 2022 |
Latest Insights into the Pathophysiology of Migraine: the ATP-Sensitive Potassium Channels.
Topics: Animals; Bronchodilator Agents; Cromakalim; Cyclic AMP; Cyclic GMP; Drug Delivery Systems; Humans; KATP Channels; Migraine Disorders; Potassium Channel Blockers | 2020 |
2 trial(s) available for cromakalim and Migraine Disorders
| Article | Year |
|---|---|
Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache.
Topics: Adenosine Triphosphate; Cromakalim; Double-Blind Method; Headache; Humans; Hypersensitivity; KATP Channels; Migraine Disorders; Post-Traumatic Headache; Tension-Type Headache | 2023 |
Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine.
Topics: Adolescent; Adult; Cromakalim; Cross-Over Studies; Double-Blind Method; Drug Delivery Systems; Female; Humans; KATP Channels; Male; Middle Aged; Migraine Disorders; Pain Measurement; Treatment Outcome; Vasodilator Agents; Young Adult | 2019 |
8 other study(ies) available for cromakalim and Migraine Disorders
| Article | Year |
|---|---|
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models.
Topics: Adenosine Triphosphate; Animals; Cromakalim; Disease Models, Animal; Humans; KATP Channels; Mice; Mice, Knockout; Migraine Disorders; Muscle, Smooth; RNA, Messenger | 2022 |
A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cromakalim; Disease Models, Animal; Humans; Hyperalgesia; Mice; Migraine Disorders; Nitroglycerin; Pain; Proto-Oncogene Proteins c-fos; Receptors, Calcitonin Gene-Related Peptide | 2022 |
PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine.
Topics: Animals; Calcitonin Gene-Related Peptide; Cromakalim; Disease Models, Animal; Drug Hypersensitivity; Mice; Migraine Disorders; Nitroglycerin; Pituitary Adenylate Cyclase-Activating Polypeptide; Signal Transduction; Sumatriptan | 2022 |
Levcromakalim provokes an acute rapid-onset migraine-like phenotype without inducing cortical spreading depolarization.
Topics: Animals; Cerebral Cortex; Cromakalim; Migraine Disorders; Phenotype; Rats; Rats, Wistar | 2023 |
CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine.
Topics: Animals; Calcitonin Gene-Related Peptide; Cilostazol; Cromakalim; Humans; Mice; Mice, Knockout; Migraine Disorders; Trigeminal Ganglion | 2021 |
The K
Topics: Cromakalim; Humans; KATP Channels; Migraine Disorders | 2017 |
Dissociation between CSD-Evoked Metabolic Perturbations and Meningeal Afferent Activation and Sensitization: Implications for Mechanisms of Migraine Headache Onset.
Topics: Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cerebrovascular Circulation; Cortical Spreading Depression; Cromakalim; KATP Channels; Male; Meninges; Migraine Disorders; Naproxen; Nociception; Nociceptors; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Ultrasonography, Doppler | 2018 |
K(ATP) channel openers in the trigeminovascular system.
Topics: Animals; ATP-Binding Cassette Transporters; Calcitonin Gene-Related Peptide; Cell Degranulation; Cromakalim; Diazoxide; Disease Models, Animal; Dura Mater; KATP Channels; Male; Mast Cells; Migraine Disorders; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Receptors, Drug; Sulfonylurea Receptors; Trigeminal Caudal Nucleus; Trigeminal Ganglion; Vasodilator Agents | 2012 |